| Reduction of benzodiazepine use in patients prescribed medical cannabis C Purcell, A Davis, N Moolman, SM Taylor Cannabis and cannabinoid research 4 (3), 214-218, 2019 | 41 | 2019 |
| Medical cannabis use among older adults in Canada: self-reported data on types and amount used, and perceived effects S Tumati, KL Lanctôt, RD Wang, A Li, A Davis, N Herrmann Drugs & aging 39 (2), 153-163, 2022 | 39 | 2022 |
| Failures in adopting green technology under perfect pollution pricing and monopoly A Davis International Review of Economics Education 26, 9-13, 2017 | 13 | 2017 |
| Explaining changes in the US credit card market: Lenders are using more information A Davis, J Kim Economic Modelling 61, 76-92, 2017 | 13 | 2017 |
| Employment and Disability Among Canadian Medical Cannabis Patients A Davis Journal of Drug Issues 49 (3), 465-476, 2019 | 1 | 2019 |
| Household Portfolio Allocation in the EU A Davis, J Kim | 1 | 2017 |
| Canadian Medical Cannabis Use after Legalization A Davis Canadian Public Policy, e2022041, 2023 | | 2023 |
| Improvement in anxiety and depressive symptoms in older adult users of medical cannabis: a retrospective observational study using validated assessment scales S Tumati, A Davis, K Sankhe, KL Lanctot, N Herrmann JOURNAL OF PSYCHIATRY & NEUROSCIENCE 47 (3), S13-S13, 2022 | | 2022 |
| A descriptive study of older medical cannabis users in medical cannabis clinics K Lanctôt, S Tumati, A Davis, G Marotta, A Li, N Herrmann The American Journal of Geriatric Psychiatry 29 (4), S109-S110, 2021 | | 2021 |
| The wealth distribution in developed and developing economies: comparing the United States to Chile using survey data from 2007 S Bauducco, G Castex, A Davis Economía chilena, vol. 22, no. 3, 2019 | | 2019 |
